• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » New Revision of ICH E6 to Add Technology and Monitoring Guidelines

New Revision of ICH E6 to Add Technology and Monitoring Guidelines

November 16, 2020

In its biannual North American meeting this month, the International Council on Harmonization (ICH) said that a third revision of its ICH E6 good clinical practices (GCP) guideline would be released in draft form in December 2021, with additional recommendations for using technologies and methods developed since its last revision in 2016.

The 2016 revision, ICH E6(R2), focused on risk-based decisionmaking, which would remain the overall focus of the revised guideline, the ICH says. But the council plans to address issues that have become prominent during the COVID-19 pandemic, such as trial decentralization, remote monitoring, digital health tools, telemedicine and use of real-world data (RWD).

The new revision will be issued in two phases, which the ICH is calling Annex 1 and Annex 2. Annex 1 will be an “overarching principles and objectives document” covering interventional clinical trials. When complete, it will replace the current E6(R2). Annex 2 will cover nontraditional clinical trials, including pragmatic and decentralized studies, as well as those incorporating RWD. Work on Annex 2 will not begin until the first draft of Annex 1 is released.

Read the ICH E6(R3) concept paper at https://bit.ly/2IBGMkp. 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing